Cardiomyopathy Trial, Recruiting (NCT05835791)

Cardiomyopathy Trial, Recruiting NCT05835791 Sponsor: Nova Scotia Health Authority Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT05835791 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had a documented episode of a fast, abnormal heart rhythm (ventricular arrhythmia) lasting more than 30 seconds, confirmed by a heart monitor, ECG, defibrillator, or implanted device recording
This is your first time being diagnosed with this type of abnormal heart rhythm (ventricular tachycardia)
You already have, or are planned to receive, an implanted heart defibrillator (ICD) during your current hospital stay
You have been diagnosed with a heart muscle disease, such as one caused by blocked arteries, thickening, enlargement, stiffening, scarring, or other structural problems of the heart muscle
You have follow-up appointments planned at an ICD clinic after leaving the hospital
You are over 18 years old

Who may not be able to join:

You may not be eligible if your abnormal heart rhythm was caused by a temporary or fixable problem (such as a medication reaction, electrolyte imbalance, or other reversible condition) rather than an ongoing heart condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michelle Samuel, MPH, PhD, Montreal Heart Institute

Phone: 902-473-4272

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05835791

Sponsor: Nova Scotia Health Authority

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 902-473-4272

More information: https://clinicaltrials.gov/study/NCT05835791

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had a documented episode of a fast, abnormal heart rhythm (ventricular arrhythmia) lasting more than 30 seconds, confirmed by a heart monitor, ECG, defibrillator, or implanted device recording
This is your first time being diagnosed with this type of abnormal heart rhythm (ventricular tachycardia)
You already have, or are planned to receive, an implanted heart defibrillator (ICD) during your current hospital stay
You have been diagnosed with a heart muscle disease, such as one caused by blocked arteries, thickening, enlargement, stiffening, scarring, or other structural problems of the heart muscle
You have follow-up appointments planned at an ICD clinic after leaving the hospital
You are over 18 years old

Who may not be able to join:

You may not be eligible if your abnormal heart rhythm was caused by a temporary or fixable problem (such as a medication reaction, electrolyte imbalance, or other reversible condition) rather than an ongoing heart condition

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nova Scotia Health Authority

Registry

ClinicalTrials.gov

Start date

12 January 2024

Est. completion

30 April 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Identification of the best sequence of treatments for a specific patient to optimize long-term outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov